Rounds Introduces Legislation to Expedite Use of AI Medical Devices for Medicare Patients
Introduce and support legislation to create a Medicare payment pathway for FDA-approved AI-enabled medical devices.
Occurrences
Evidence
The current legislation archive for Sen. Mike Rounds shows recent 2026 items on AI in agriculture (S.4627), a national AI research resource (S.4441), AI literacy (S.4414), rural transit, water projects, and financial regulation, but it does not show any bill about a Medicare payment pathway for FDA-approved AI-enabled medical devices.
The current press-release archive shows Rounds's recent actions on the FY2027 NDAA, semiconductor smuggling, Department of Education discussions, tribal radio funding, lab-grown meat oversight, small-business capital access, rural transit, housing, and Wounded Knee legislation. It does not show any June 2026 release announcing or supporting legislation for a Medicare payment pathway for FDA-approved AI-enabled medical devices.
The Senate AI Working Group roadmap backed by Rounds says health care AI policy should include FDA tools, transparency for AI medical products, and examining CMS reimbursement mechanisms, but it frames this as committee consideration rather than a bill creating a Medicare payment pathway for FDA-approved AI-enabled medical devices.
Rounds announced a five-bill AI package: GUIDE AI for biomedical data, financial-services AI sandboxes, consumer AI literacy, financial-services AI reporting, and a Defense Department AI pilot. The listed package does not include a Medicare payment pathway for FDA-approved AI-enabled medical devices.
The GUIDE AI Act text concerns NIH AI resources, biomedical datasets, ONC interoperability standards, and a Medicare hospital requirement for sharing electronic health record data for research. It does not establish Medicare payment for FDA-approved AI-enabled devices.
Rounds's current legislation archive lists recent AI items such as S.4627 on agriculture AI, S.4441 on the National Artificial Intelligence Research Resource, and S.4414 on AI literacy, plus unrelated Medicare physical-therapy legislation. It does not show a Medicare payment pathway for FDA-approved AI-enabled medical devices in the visible current records.
The current press-release archive shows recent Rounds releases on defense, semiconductors, education, lab-grown meat, small business capital, rural transit, housing, and other topics. The visible 2026 archive does not announce legislation creating a Medicare payment pathway for FDA-approved AI-enabled medical devices.
Assessments
Rounds supported and helped advance broader Senate AI health-policy work that mentioned examining CMS reimbursement mechanisms for AI in health care, but the evidence does not show that he introduced, sponsored, or supported legislation creating a Medicare payment pathway for FDA-approved AI-enabled medical devices. His later AI package and GUIDE AI Act addressed biomedical data, interoperability, literacy, and other AI issues, not Medicare device payment. This warrants partial credit for related same-term policy activity, not full delivery.
Primary-source evidence located here does not show Mike Rounds introducing or backing the specific promised legislation. His official August 27, 2024 AI policy package listed five AI bills on biomedical data, financial-services sandboxes and reporting, AI literacy, and a Defense Department pilot, but not a Medicare payment pathway for FDA-approved AI-enabled medical devices. His official legislation and press-release archives reviewed through 2026 likewise do not show a bill matching this promise. Because the claim is about taking a specific legislative action and the available record does not confirm that action, but he remains in office and the record here is not definitive enough to rule it out permanently, the best judgment is unresolved rather than delivered or never.